2.1M
XNAS Volume
High volume+loss today
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Markus Warmuth | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 128,000 | 544,538 | - | - | Common Stock | |
| Markus Warmuth | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 575,000 | 575,000 | - | - | Stock Option (Right to Buy) | |
| Sharon Townson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 36,000 | 36,000 | - | - | Common Stock | |
| Sharon Townson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 161,000 | 161,000 | - | - | Stock Option (Right to Buy) | |
| Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 161,000 | 161,000 | - | - | Stock Option (Right to Buy) | |
| Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 36,000 | 45,189 | - | - | Common Stock | |
| Phil Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 36,000 | 36,000 | - | - | Common Stock | |
| Phil Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 161,000 | 161,000 | - | - | Stock Option (Right to Buy) | |
| Edmund Dunn | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 53,400 | 53,400 | - | - | Stock Option (Right to Buy) | |
| Edmund Dunn | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 11,850 | 25,794 | - | - | Common Stock | |
| Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 30,000 | 30,000 | - | - | Common Stock | |
| Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Hughes Eric A | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2024 | 44,200 | 44,200 | - | - | Stock Option (Right to Buy) | |
| Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Edmund Dunn | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.83 per share. | 05 Jul 2024 | 1,610 | 13,944 | - | 3.8 | 6,166 | Common Stock |
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,100 | 22,100 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,100 | 22,100 | - | - | Stock Option (Right to Buy) | |
| Anthony M. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,100 | 22,100 | - | - | Stock Option (Right to Buy) | |
| Christine Siu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,100 | 22,100 | - | - | Stock Option (Right to Buy) | |
| Jan Skvarka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,100 | 22,100 | - | - | Stock Option (Right to Buy) | |
| Kimberly L. Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,100 | 22,100 | - | - | Stock Option (Right to Buy) | |
| Sharon Townson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Phil Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Edmund Dunn | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 4.04 per share. | 03 Jun 2024 | 1,207 | 15,554 | - | 4.0 | 4,876 | Common Stock |
| Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Nickson Philip | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 109,000 | 109,000 | - | - | Stock Option (Right to Buy) | |
| Dunn Edmund | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Jullian G. Jones | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 79,000 | 79,000 | - | - | Stock Option (Right to Buy) | |
| Janku Filip | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 121,000 | 121,000 | - | - | Stock Option (Right to Buy) | |
| Owen Wallace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 119,000 | 119,000 | - | - | Stock Option (Right to Buy) | |
| Warmuth Markus | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 346,000 | 346,000 | - | - | Stock Option (Right to Buy) | |
| Edmund Dunn | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Anthony M. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 41,000 | 41,000 | - | - | Stock Option (Right to Buy) | |
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (Right to Buy) | |
| Christine Siu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (Right to Buy) | |
| Jan Skvarka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (Right to Buy) | |
| Alexander Mayweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (Right to Buy) | |
| Kimberly Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (Right to Buy) | |
| Jan Skvarka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 41,000 | 41,000 | - | - | Stock Option (Right to Buy) | |
| Markus Warmuth | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 472,000 | 472,000 | - | - | Stock Option (Right to Buy) | |
| Owen Wallace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Ajim Tamboli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 129,850 | 129,850 | - | - | Stock Option (Right to Buy) | |
| Sharon Townson | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 78,550 | 78,550 | - | - | Stock Option (Right to Buy) | |
| John Castle | Chief Data Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 78,500 | 78,500 | - | - | Stock Option (Right to Buy) | |
| Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Philip Nickson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 123,650 | 123,650 | - | - | Stock Option (Right to Buy) | |
| Jullian G. Jones | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 77,450 | 77,450 | - | - | Stock Option (Right to Buy) | |
| Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Christine Siu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Alexander Mayweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Kimberly Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Markus Warmuth | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 315,600 | 315,600 | - | - | Stock Option (Right to Buy) | |
| Owen Wallace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 117,450 | 117,450 | - | - | Stock Option (Right to Buy) | |
| Ajim Tamboli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 111,700 | 111,700 | - | - | Stock Option (Right to Buy) | |
| Sharon Townson | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| John Castle | Chief Data Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 53,700 | 53,700 | - | - | Stock Option (Right to Buy) | |
| Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 86,500 | 86,500 | - | - | Stock Option (Right to Buy) | |
| Philip Nickson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 70,600 | 70,600 | - | - | Stock Option (Right to Buy) | |
| Jullian G. Jones | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 73,300 | 73,300 | - | - | Stock Option (Right to Buy) | |
| Anthony A. Florence | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Anthony A. Florence | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Anthony A. Florence | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Anthony A. Florence | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Anthony A. Florence | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Anthony A. Florence | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Anthony A. Florence | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Edward T. Mathers | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Edward T. Mathers | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Edward T. Mathers | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Edward T. Mathers | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Edward T. Mathers | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Edward T. Mathers | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Edward T. Mathers | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Sandell D Scott | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Sandell D Scott | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Sandell D Scott | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Sandell D Scott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Sandell D Scott | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Sandell D Scott | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Sandell D Scott | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Forest Baskett | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Forest Baskett | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Forest Baskett | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Forest Baskett | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Forest Baskett | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Forest Baskett | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Forest Baskett | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Joshua Makower | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Joshua Makower | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Joshua Makower | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Joshua Makower | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Joshua Makower | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Joshua Makower | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Joshua Makower | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Paul Walker | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Paul Walker | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Paul Walker | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Paul Walker | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Paul Walker | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Paul Walker | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Paul Walker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Liza K. Landsman | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Liza K. Landsman | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Liza K. Landsman | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Liza K. Landsman | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Liza K. Landsman | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Liza K. Landsman | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Liza K. Landsman | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 2,699,328 | 0 | - | - | Series C convertible preferred stock | ||
| Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 6,515,869 | 6,799,115 | - | - | Common Stock | ||
| Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 1,940,043 | 1,940,043 | - | - | Common Stock | ||
| Bradley J. Bolzon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 157,895 | 2,097,938 | - | 19 | 3,000,005 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 20,004,280 | 0 | - | - | Series A convertible preferred stock | ||
| Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 3,000,000 | 0 | - | - | Series B convertible preferred stock | ||
| Bradley J. Bolzon | Director, Ten Percent Owner | 28 Jun 2021 | 4,150,000 | 0 | - | - | Series B convertible preferred stock | ||
| Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Ali Behbahani | Director, Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Ali Behbahani | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Peter Sonsini | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Peter Sonsini | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Peter Sonsini | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Peter Sonsini | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Peter Sonsini | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Peter Sonsini | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Peter Sonsini | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Carmen Chang | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Carmen Chang | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Carmen Chang | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Carmen Chang | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Carmen Chang | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Carmen Chang | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Carmen Chang | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Mohamad Makhzoumi | Ten Percent Owner | 28 Jun 2021 | 2,361,912 | 0 | - | - | Series C convertible preferred Stock | ||
| Mohamad Makhzoumi | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 28 Jun 2021 | 1,050,000 | 7,692,298 | - | 19 | 19,950,000 | Common Stock |
| Mohamad Makhzoumi | Ten Percent Owner | 28 Jun 2021 | 9,588,725 | 0 | - | - | Series A-2 convertible preferred stock | ||
| Mohamad Makhzoumi | Ten Percent Owner | 28 Jun 2021 | 11,500,000 | 0 | - | - | Series B convertible preferred stock | ||
| Mohamad Makhzoumi | Ten Percent Owner | 28 Jun 2021 | 3,257,328 | 5,973,296 | - | - | Common Stock | ||
| Mohamad Makhzoumi | Ten Percent Owner | 28 Jun 2021 | 669,002 | 6,642,298 | - | - | Common Stock | ||
| Mohamad Makhzoumi | Ten Percent Owner | 28 Jun 2021 | 2,715,968 | 2,715,968 | - | - | Common Stock | ||
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 47,132 | 47,132 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 47,132 | 47,132 | - | - | Stock Option (Right to Buy) | |
| Alexander Mayweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 47,132 | 47,132 | - | - | Stock Option (Right to Buy) | |
| Chandra Leo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 47,132 | 47,132 | - | - | Stock Option (Right to Buy) | |
| Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 387,069 | 387,069 | - | - | Stock Option (Right to Buy) | |
| Christine Siu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 47,132 | 47,132 | - | - | Stock Option (Right to Buy) | |
| Christine Siu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 7,081 | 7,081 | - | - | Stock Option (Right to Buy) | |
| Markus Warmuth | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 538,517 | 538,517 | - | - | Stock Option (Right to Buy) | |
| Markus Warmuth | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 141,623 | 141,623 | - | - | Stock Option (Right to Buy) | |
| Owen Wallace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 113,298 | 113,298 | - | - | Stock Option (Right to Buy) | |
| Owen Wallace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 387,069 | 387,069 | - | - | Stock Option (Right to Buy) | |
| Kimberly Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 7,081 | 7,081 | - | - | Stock Option (Right to Buy) | |
| Kimberly Blackwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 47,132 | 47,132 | - | - | Stock Option (Right to Buy) | |
| Ajim Tamboli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 100,938 | 100,938 | - | - | Stock Option (Right to Buy) | |
| Ajim Tamboli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 56,649 | 56,649 | - | - | Stock Option (Right to Buy) | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 47,132 | 47,132 | - | - | Stock Option (Right to Buy) | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 2,075,000 | 4,150,000 | - | - | Series B convertible preferred stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 2,699,328 | 2,699,328 | - | - | Series C convertible preferred stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 1,500,000 | 3,000,000 | - | - | Series B convertible preferred stock |